Supply Chain Safety’s Dual Visions: Pedigree Or Just Serialization
This article was originally published in The Pink Sheet Daily
Executive Summary
As Congress considers how to ensure downstream supply chain security, industry groups are looking at a process to link drugs to their manufacturer. But in a recent communication with the Senate HELP Committee, FDA backs a “comprehensive national track-and-trace system.”